An overview of the BOIN design and its current extensions for novel . . . Bayesian Optimal Interval (BOIN) designs are a class of model-assisted dose-finding designs that can be used in oncology trials to determine the maximum tolerated dose (MTD) of a study drug based on safety or the optimal biological dose (OBD) based
Bayesian Optimal Interval (BOIN) Design for Phase I Clinical Trials BOIN Suite: A Software Platform to Design and Implement Novel Early-Phase Clinical Trials JCO Clinical Cancer Informatics, 5, 91-101 Cite the software: Zhou, Y , Liu, Y , Yuan, Y , Lee, J J , Zhou, H , Chen, N , Kuo, Y (2026) Bayesian Optimal Interval (BOIN) Design for Phase I Clinical Trials (V3 0 17 0) [Computer software]
Bayesian Optimal Interval (BOIN) - Clinical Biostats The Bayesian Optimal Interval (BOIN) design is a structured approach for dose-finding in phase I clinical trials It aims to balance effective dose escalation with patient safety by using observed dose-limiting toxicity (DLT) rates to guide dose adjustments
Bayesian Optimal Interval Design: A Simple and Well-Performing Design . . . Abstract Despite more than two decades of publications that offer more innovative model-based designs, the classical 3 + 3 design remains the most dominant phase I trial design in practice In this article, we introduce a new trial design, the Bayesian optimal interval (BOIN) design
Blockchain Innovation Network Inc Announces Comprehensive Upgrade to . . . United States, March 23, 2026 -- At a pivotal moment marked by deeper regulatory compliance and technological innovation in the global digital asset market, BOIN Exchange, a leading global digital asset trading platform developed by Blockchain Innovation Network Inc, has officially announced a major upgrade to its global strategy This upgrade is designed to deliver a safer, more efficient